Atlas FDA

Biodesign Otologic Repair Graft

FDA 510(k) clearance K161000 · decided 2016-05-11

Clearance details

K-number
K161000
Device name
Biodesign Otologic Repair Graft
Applicant
Cook Biotech Incorporated
Decision
Substantially Equivalent
Date received
2016-04-11
Decision date
2016-05-11
Days to decision
30 days
Clearance type
Special
Product code
KHJ
Device class
2
Regulation number
874.3620
Medical specialty
Ear, Nose, Throat
Advisory committee
Ear, Nose, Throat
Location
West Lafayette, IN, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Cook Biotech Incorporated

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
Biodesign Otologic Butterfly Graft (ENT-OTO-BFLY-0.4-0.6); Biodesign Otologic Butterfly Graft (ENT-OTO-BFLY-0.6-0.9) (K232646)Cook Biotech Incorporated2024-05-24
Biodesign Otologic Repair Graft (K150594)Cook Biotech Incorprated2015-09-16
ADAPTAIN, ADAPTAIN FASTWRAP, ENVELOCK, BIOWAI (K132198)Ceremed , Inc.2013-09-12
BIODESIGN ENT REPAIR GRAFT (K121360)Cook Biotech Incorprated2013-02-27
ADAPTAIN FASTWRAP, ENVELOCK, GRAFTAIN (K122561)Ceremed , Inc.2012-11-27
ADAPTAIN SOLUBLE IMPLANT MATERIAL (K120220)Ceremed , Inc.2012-06-06
CERETENE SOLUBLE IMPLANT MATERIAL (K103047)Ceremed , Inc.2011-01-05
GEL-SPONGE ENT, ABSORBABLE GELATIN SPONGE, USP (K080022)Vascular Solutions, Inc.2008-12-09
AOC, OSTENE, AOC IMPLANT MATERIAL, CERETENE, OSTENE LUBE, AOC-LV (K082245)Ceremed , Inc.2008-09-18
AOC SOLUBLE IMPLANT MATERIAL (K081531)Ceremed , Inc.2008-07-18
OSTENE, AOC, OSTEOTENE, CERETENE, CEREPOR, APTENE, APATENE, ACTIPASTE (K070093)Ceremed , Inc.2007-01-24
OSTENE, AOC, OSTEOTENE, CERETENE, CEREPOR, APTENE, APATENE AND ACTIPASTE (K062280)Ceremed , Inc.2006-12-11

Recalls involving this device

No recalls on record reference this clearance.